Production of Abnormal Protein Form Linked to Pathogenesis of C9orf72 ALS Mutation
A new study published in the journal Neuron, conducted by Helene Tran, Ph.D. and Fen-Biao Gao, Ph.D.,…
Articles by Margarida Azevedo, MSc
Target ALS Postmortem Tissue Core Now Includes Pre-Mortem Samples in Collection
The ALS Association, the nation’s leading non-profit organization dedicated to addressing Lou Gehrig’s disease in both research initiatives and patient support…
Study on NeuRx Diaphragm Pacing System for ALS-Related Hypoventilation Suspended by NEALS Due to Slow Patient Recruitment
The Northeast ALS Consortium (NEALS) Data and Safety Monitoring Board (DSMB) recently issued Synapse Biomedical Inc. a notice to suspend amyotrophic lateral…
Neuraltus and Clinigen Group Launch NP001 Managed Access Program in Europe for ALS
Neuraltus Pharmaceuticals, Inc. recently announced it has partnered with the Clinigen Group plc’s Idis Managed Access (MA) division to launch a…
100 ALS Community Members Create New Drug Development Guidance
The ALS Association, the country’s premier organization committed to find a cure for ALS and improving the lives of those…
Johns Hopkins, Cedars-Sinai, and Massachusetts General Partner in Largest Project for Answer ALS
Three prominent health institutions have recently come together to form the country’s largest coordinated and comprehensive initiative against amyotrophic lateral sclerosis…
Karyopharm Therapeutics Announces Advance of Neuroprotective SINE(TM) Compounds for Amyotrophic Lateral Sclerosis
Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs for the…
Synapse Biomedical To Present Data on NeuRx Diaphragm Pacing System In ALS Patients
Synapse Biomedical Inc., a company that commercializes the NeuRx Diaphragm Pacing System (DPS), has recently announced it will be presenting…
Biohaven Acquires Global Rights to 300 Investigational ALS Biopharma Products
Portage Biotech, Inc. together with privately-held Biohaven Pharmaceutical Holding Company Ltd. has just acquired global intellectual property rights to an…
Biogen, ALS Association and Columbia University Medical Center Partner to Expand Genetic Resources and Research
A new research collaboration was recently formed between Biogen Idec, the ALS Association and Columbia University Medical Center (CUMC) to study…